Trials / Completed
CompletedNCT04214808
To Evaluate the Pharmacokinetics and Safety of AD-208
A Randomized, Open-label, Single-dose, Crossover Study to Evaluate the Pharmacokinetics and Safety of AD-208
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Addpharma Inc. · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To evaluate pharmacokinetics and safety of AD-208.
Detailed description
The purpose is that pharmacokinetics and safety of AD-208 in healthy adult male volunteers are evaluated as compared to Avodart Soft Capsule 0.5mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AD-208 | Dutasteride 0.2mg |
| DRUG | Avodart Soft Capsule 0.5mg | Dutasteride 0.5mg |
Timeline
- Start date
- 2020-01-03
- Primary completion
- 2020-02-04
- Completion
- 2020-05-04
- First posted
- 2020-01-02
- Last updated
- 2020-12-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04214808. Inclusion in this directory is not an endorsement.